Literature DB >> 31930216

Retinol binding protein 3 as biomarker for diabetic retinopathy.

Ward Fickweiler1,2, Lloyd P Aiello1,2,3, Jennifer K Sun1,2,3, George L King1,3,4.   

Abstract

Entities:  

Year:  2019        PMID： 31930216      PMCID： PMC6944560          DOI： 10.21037/atm.2019.10.95

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

1.  Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.

Authors:  Hisashi Yokomizo; Yasutaka Maeda; Kyoungmin Park; Allen C Clermont; Sonia L Hernandez; Ward Fickweiler; Qian Li; Chih-Hao Wang; Samantha M Paniagua; Fabricio Simao; Atsushi Ishikado; Bei Sun; I-Hsien Wu; Sayaka Katagiri; David M Pober; Liane J Tinsley; Robert L Avery; Edward P Feener; Timothy S Kern; Hillary A Keenan; Lloyd Paul Aiello; Jennifer K Sun; George L King
Journal:  Sci Transl Med       Date:  2019-07-03       Impact factor: 17.956

2.  C-reactive protein, body mass index, and diabetic retinopathy.

Authors:  Laurence Shen Lim; E Shyong Tai; Paul Mitchell; Jie Jin Wang; Wan Ting Tay; Ecosse Lamoureux; Tien Yin Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-09       Impact factor: 4.799

3.  Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study.

Authors:  M V van Hecke; J M Dekker; G Nijpels; A C Moll; R J Heine; L M Bouter; B C P Polak; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-05-26       Impact factor: 10.122

4.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Authors:  M T Schram; N Chaturvedi; C G Schalkwijk; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

5.  Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.

Authors:  Monique S Roy; Malvin N Janal; Juan Crosby; Robert Donnelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

6.  Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

Authors:  Jennifer K Sun; Hillary A Keenan; Jerry D Cavallerano; Bela F Asztalos; Ernst J Schaefer; David R Sell; Christopher M Strauch; Vincent M Monnier; Alessandro Doria; Lloyd Paul Aiello; George L King
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

7.  Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes.

Authors:  Sonia L Hernandez; Jennifer H Gong; Liming Chen; I-Hsien Wu; Jennifer K Sun; Hillary A Keenan; George L King
Journal:  Diabetes Care       Date:  2014-04-29       Impact factor: 19.112

8.  Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.

Authors:  Subhadip Choudhuri; Deep Dutta; Aditi Sen; Imran Hussain Chowdhury; Bhaskar Mitra; Lakshmi Kanta Mondal; Avijit Saha; Gautam Bhadhuri; Basudev Bhattacharya
Journal:  Mol Vis       Date:  2013-01-28       Impact factor: 2.367

9.  Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy.

Authors:  I K Lee; K Y Park; H K Oh; R W Park; J S Jo
Journal:  J Korean Med Sci       Date:  1994-08       Impact factor: 2.153

Review 10.  Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.

Authors:  Olga Simó-Servat; Rafael Simó; Cristina Hernández
Journal:  J Diabetes Res       Date:  2016-06-08       Impact factor: 4.011
  10 in total
  3 in total

1.  Elevated Retinol Binding Protein 3 Concentrations Are Associated With Decreased Vitreous Inflammatory Cytokines, VEGF, and Progression of Diabetic Retinopathy.

Authors:  Ward Fickweiler; Hyunseok Park; Kyoungmin Park; Margalit G Mitzner; Tanvi Chokshi; Tahani Boumenna; John Gautier; Yumi Zaitsu; I-Hsien Wu; Jerry Cavallerano; Lloyd P Aiello; Jennifer K Sun; George L King
Journal:  Diabetes Care       Date:  2022-09-01       Impact factor: 17.152

Review 2.  Discoveries from the study of longstanding type 1 diabetes.

Authors:  Bruce A Perkins; Leif Erik Lovblom; Sebastien O Lanctôt; Krista Lamb; David Z I Cherney
Journal:  Diabetologia       Date:  2021-03-04       Impact factor: 10.122

3.  Hyperglycemia-induced increasing of RELB/circ_0008590 in NF-κB pathway is repressed by miR-1243 in human retinal microvascular endothelial cells.

Authors:  Jun Shao; Jiping Cai; Yong Yao; Hui Zhu
Journal:  Ann Transl Med       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.